The first crystal structure of Class II peptide deformylase has been determined. The enzyme from Staphylococcus aureus has been over-expressed and purified in Escherichia coli and the structure determined by X-ray crystallography to 1.9 Å resolution. The purified iron-enriched form of S. aureus peptide deformylase enzyme retained high activity over many months. In contrast, the iron-enriched form of the E. coli enzyme is very labile. Comparison of the two structures details many differences; however, there is no structural explanation for the dramatic activity differences we observed. The protein structure of the S. aureus enzyme reveals a fold similar, but not identical to the well-characterized Escherichia coli enzyme. The most striking deviation of the S. aureus from E. coli structure is the unique conformation of the C-terminal amino acids. The distinctive C-terminal helix of the latter is replaced by a strand in S. aureus that wraps around the enzyme terminating near the active site. While there are no differences at the amino acid level near the active site metal ion, significant changes are noted in the peptide binding cleft that may play a role in the design of general peptide deformylase inhibitors.
INTRODUCTION
Antibiotics that target cell wall biosynthesis, protein synthesis or DNA replication in bacteria, have been the mainstay for treatment of bacterial infections for decades. However, in recent times antibiotic resistant bacteria have become a major health threat 1 . This unmet medical need has prompted a new interest in the development of novel, potent, and orally available antibiotics.
Among the many potential approaches to new antibiotics include those that target novel, bacterial specific, biosynthetic pathways. Peptide deformylase is such a target. Inhibition of this enzyme would result in blockage of essential protein processing and has been shown to be bacteriostatic [2] [3] .
In eubacteria, as well as mitochondria and chloroplasts, the initiation of protein synthesis normally requires an N-formylated methionine residue [4] [5] [6] . The special initiation tRNA, tRNA f Met , is charged with methionine by the methionyl-tRNA synthetase (EC 6.1.10) which adds a methionine to either of the methionine tRNAs with the consumption of ATP. The formyl group is added to the charged tRNA f Met from 10-formyltetrahydrofolate by methionine-tRNA f Met formyl-transferase (EC 2.1.2.9). The f-Met-tRNA f Met is transferred to the ribosome where it is the preferred initiator of protein synthesis 7 . Mature proteins do not retain N-formyl methionine.
In fact, a heterogeneous population of amino acids is normally found at the N-terminus of mature proteins---alanine, glycine, serine, threonine or methionine. Larger amino acids are rarely found 6, 8, 9 . This observation suggests that multiple catabolic processing might occur after or in concert with protein synthesis. This processing may be important for protein turnover 10 , conservation of methionine, or may be required for the activity of some enzymes [11] [12] [13] . All known amino-terminal peptidases cannot use formylated peptides as substrates 14 . Thus, removal of the formyl group is an essential first step in N-terminal processing. The formyl group is removed from the peptide amino-terminus by a metalloenzyme, peptide deformylase (EC 3.5.1.27) [15] [16] [17] . The processed protein is released for possible further processing by methionine aminopeptidase (EC 3.4.11.18).
Because the formylation/deformylation cycle is unique to eubacteria and does not occur in cytosolic eucaryotic or archaebacteria protein synthesis 4 , peptide deformylase is an attractive target for the design of new antibiotics.
Previous analysis of peptide deformylase gene sequences revealed that the predicted protein coding regions have a significant sequence similarity and three characteristic stretches of highly conserved amino acids: motif 1 (GΦGΦAAXQ), motif 2 (EGCΦS), and motif 3 (HEΦDH),
where Φ is a hydrophobic amino acid ( Figure 1 ). The Cys of motif 2 and the two His residues of motif 3 are involved in active site metal ion binding 18 . The fourth ligand of the tetrahedrally coordinated metal ion is a water molecule that is held in place by the Glu of motif 3. Subsequent analysis of diverse peptide deformylase sequences suggested that the enzyme family could be divided into two classes 19 . Peptide deformylase enzyme from gram-negative organisms
represented by E. coli (Class I) have approximately 30% sequence identity with each other;
whereas, many gram-positive organisms express a structural variant that includes three major insertions [20] [21] relative to the E. coli sequence, some additional single amino acid insertions, and a distinct C-terminus ( Figure 1 ). The overall sequence identity among Class II genes appears to be lower (15%) than Class I and about half of these identities occur in or near the Class II specific insertions. The first major insertion occurs after Tyr 39 (E. coli) and consists of twelve amino acids with high sequence similarity. In this region the Mycoplasma genes predict an insertion of only eleven amino acids 22 . The second characteristic insertion is of variable length and occurs after Asn 65 . A third insertion of three amino acids follows Ser 81 and extends the sequence preceding the conserved motif 2. The last major difference between the two classes is the C-terminus. In the Class II enzymes this sequence is more hydrophobic and nearly always shorter than the E. coli version.
Class I peptide deformylase from the gram-negative organism, E. coli, has been wellcharacterized both in terms of enzymology and structure. Efforts to purify the enzyme were hampered for 3 decades by the rapid loss of activity upon purification. This lability was traced to the Fe +2 metal co-factor 23 and has been overcome by a combination of protein over-expression, elimination of oxygen, and the use of alternative active site metal ions. The Zn +2 form of the enzyme displays about a 100-fold drop in activity relative to Fe +2 peptide deformylase [23] [24] [25] [26] , is abundantly produced during over-expression, and is much more stable than the iron version 27 .
Nickel +2 , Co +2 or Cd +2 substituted peptide deformylase retains nearly identical activity with the Fe +2 enzyme, but are much less susceptible to oxidation 26, [28] [29] [30] . The X-ray and NMR structures of E. coli peptide deformylase have been reported. The ligand-free structure of the enzyme was first reported by Chan et al 31 . They subsequently determined the structure of the complex of peptide deformylase with the a transition state inhibitor, [32] [33] 35 . The focal point of the overall fold of the protein is α helix 3 that includes the HEXXH metal binding sequence, motif 3. Positioned about this α helix are three small β sheets that cradle the helix and form a shallow depression for peptide binding 31, 43 . The
Class I enzyme has a long C-terminal α helix that extends away from the body of the enzyme.
Genetic evidence suggests that this α helix can be deleted without loss of function in E. coli 44 .
In this report we present the X-ray structure of Class II peptide deformylase from the grampositive pathogen Staphylococcus aureus at 1.9 Å resolution. Comparison of this structure with the prototypic Class I enzyme from E. coli reveals minor structural variation arising from the insertions as well as specific, active site differences that may impact the design of pathogen specific peptide deformylase inhibitors.
Experimental Procedures

Cloning and Expression
The S. aureus peptide deformylase sequence was identified from Human Genome Science (contig number 168951) and cloned directly from S. aureus RN4220 genomic DNA to complete the open reading frame. The gene from strain RN4220 has the same peptide deformylase sequence as strain N315 (Figure 1) The open reading frame of E. coli peptide deformylase was amplified using polymerase chain reaction from an E. coli genomic library. Restriction enzyme Bgl II sites were engineered onto both ends and the resulting insert was ligated into the Bgl II site of the E. coli expression vector pQE60 (Qiagen). Both constructs express peptide deformylase followed by a C-terminal hexahistidine tag.
The peptide deformylase proteins were expressed using Luria Broth (LB) with ampicillin (100 mg/L) in both the seed and production media. LB was prepared using Bacto-tryptone (10g);
Bacto yeast (5g) and NaCl (5g) added per L of deionized water. The pH of the media was adjusted to 7.5 with KOH before sterilization. The LB was autoclaved for 20 minutes in 100 mL volumes in 500 mL wide mouth fermentation flasks. Ampicillin was filter sterilized and added just before inoculation. The 100 mL seed stock fermentations were carried out in 500 mL wide mouth flasks and were inoculated from agar cultures and were incubated overnight at 37°C with agitation at 200 rpm. The seed fermentations were used to inoculate at 2% the 100 mL production fermentations that were also carried out in 500 mL wide mouth flasks. These fermentations were incubated with agitation at 200 rpm for slightly longer than 2 hours and were then induced (OD 660 nm reached 0.6). IPTG was added to a final concentration of 0.4 mM. The induced fermentations were continued for an additional 3.5 hours until the OD reached 3.0.
Multiple fermentations produced a final harvest of 4-6 liters for purification. The two forms of peptide deformylase were collected separately for further analysis. No differences in SDS-PAGE mobility or purity were observed. The first fraction had optimal activity while the second fraction had much less specific activity. Protein eluted in the early fraction of the gradient was collected and further concentrated in a stirred cell to the desired volume. Peptide deformylase was either prepared for crystallization experiments, or could be mixed with 50% glycerol and stored at -20ºC. Enzyme assays have demonstrated that peptide deformylase is stable without catalase for over one year when stored in 50% glycerol at -20ºC.
Selenomethionine peptide deformylase was purified for crystallization efforts as described above with the inclusion of 5mM βME.
Peptide Deformylase Activity measurements
The activity of S. aureus peptide deformylase was evaluated using two different assays, based in part on the methods of Wei and Pei 46 , for which coupling of the product of the peptide deformylase reaction (Met-Leu-p-nitroanilide) to Vibrio aminopeptidase is required, and Lazennec and Meinnel, 47 for which coupling of the peptide deformylase reaction (formic acid generated from formyl-Met-Ala-Ser) to formate dehydrogenase is required. For the former assay method, a Vibrio Proteolyticus aminopeptidase strain was obtained from Dehua Pei at Ohio State University. Stocks of the organism were prepared from 16 hour cultures grown in Difco Marine Broth with 20% glycerol added as a cryo-preservative and were stored in liquid nitrogen vapor phase. The production of aminopeptidase followed the published procedure 48 , but excluded the Q Sepharose fast flow column step and included an octyl Sepharose step 49 . The resulting preparation was concentrated by Amicon ultrafiltration to greater than 2.5 mg/ml, was stored in 50% glycerol at -20 o C.
The final aminopeptidase coupled assay solution contained 50 mM Na Hepes, 10 mM NaCl, pH minute time course at 25°C. In some cases we also used a third direct C-18 HPLC assay that lacked the coupling enzymes. For the HPLC assay, we followed the generation of the product Met-Leu-p-nitroanilide described in the reaction above, using UV absorbance at 315 nm.
Comparison of the stability of the iron-enriched S. aureus peptide deformylase with ironenriched E. coli peptide deformylase -Expression of the iron form of S. aureus or E. coli peptide deformylase in E. coli (both JM109) was completed after the pre-incubation of the cells in 1.6 mM FeCl 3 in Luria broth. Incubation was allowed to proceed for 1 hour prior to the addition of IPTG (0.4 mM). Induction continued for 3 hours at 37 o C. Isolated cells were extracted in the presence of catalase (10 µg/mL). The extracts were subjected to Ni-NTA chromatography for the purification of the C-terminally hexahistidine tagged versions of both the E. coli and S. aureus enzymes. The purified proteins (concentrated to at least 1 mg/ml by Amicon ultrafiltration) were then stored in 10 µg/mL (minimum concentration) catalase. To examine the stability of the iron-enriched forms of the peptide deformylase proteins, dilutions of the enzymes were made in the presence or absence of catalase (at 100 µg/mL), followed by enzymatic assays. Assays were run using formyl-Met-Leu-p-nitroanilide as substrate, coupled to the Vibrio aminopeptidase. Similarly, the metal forms of S. aureus peptide deformylase were prepared by supplementation of E. coli K12 with 1.6 mM FeCl 3 , 640 uM ZnCl 2, or control media, followed by purification by Ni-NTA chromatography as described above (in the absence of catalase) 26, 29 . The peptide deformylase from each experiment (iron-enriched, zinc-enriched, or no supplementation) was then assayed as described above.
Metal Ion Assessment
X-ray fluorescence experiments were carried out at the Advanced Photon Source beamline 17ID 
Structure Determination
The X-ray data for the MAD phasing of peptide deformylase was collected at the Advanced Photon Source on beamline 17ID operated by the Industrial Macromolecular Crystallography Association, and consisted of three separate wavelength experiments centered about the Selenium Kappa edge (low, 1.03321 Å; edge, 0.97939 Å, inflection point; high, 0.97928 Å, peak of the absorption edge). The appropriate X-ray wavelength was selected using the 111 reflection from a cryo-cooled Si monochromator crystal. This beam was passed through a 0.15 x 0.15 mm pair of slits before striking the sample. The data were collected from the cryo-cooled SeMethionine peptide deformylase crystal with a 2K x 2K Brűker CCD detector mounted upon a Kappa goniometer in an inverse beam mode. Each scan consisted of 300 frames each of which was a 0.5 degree oscillation about the phi axis. A second scan beginning at phi = 180° was accomplished before the wavelength was changed. Each frame was exposed for 0.5 sec and the crystal to detector distance was 15 cm. Data sets at each wavelength were indexed and processes separately with the program SAINT (Siemens Analytical X-ray Systems, Madison, WI) while keeping the anomalous pairs separate. The data collection and statistics are summarized in Table   1 . The inflection point and peak data sets were scaled to the remote energy data set (low) using the program SCALEIT in the CCP4 Program Suite 51 by treating the remote as the native.
Anomalous and dispersive difference Patterson maps revealed six selenium sites whose locations were determined and refined by direct methods using the automated Patterson solution routine in SHELX 52 . Heavy atom refinement and phase calculations were carried out using MLPHARE 53 with all the data from 10 to 1.9 Å resolution. The resulting electron density map was readily interpreted and a model built (Figure 4a) . A density modified map 54 was also calculated, but this map was not very different from the MAD map. Model building was done with the graphics package CHAIN 55 and LORE 56 . The structure was refined with CNX 2000.1 (Molecular Simulations Inc.) positional refinement 57 using the remote (low) data set and included three cycles of manual intervention. The active site waters and a zinc atom were incorporated into the model by direct examination of the 2Fo-Fc map, but subsequent water addition was done automatically with CNX using 3 σ peaks in the Fo-Fc map and a hydrogen-bonding requirement.
Waters without 1 σ 2Fo-Fc electron density and/or B-factors above 65 Å 2 were removed from the model. The final R-factor is 18.0% with a Free-R-factor of 21.2% for data from 10 to 1.9 Å resolution. The final agreement statistics (Table 2 ) reveal a well-refined structure. The final model included 1452 protein atoms and encompassed residues Met 1 (with a free amino group) through His 184 (from the purification tag). The remaining residues from the purification tag were not ordered in the electron density map. There were no disordered internal main chain atoms.
Additional statistics were generated with PROCHECK 58 . A view of the initial MAD map and the final protein model in the region of the active metal ion is given in Figure 4a and was produced using MOSAIC2 (J.B. Moon, unpublished).
The final S. aureus peptide deformylase and the E. coli peptide deformylase complex with (S)-2- 32 (1bsj.pdb) were compared using SUPERPDB (B.C. Finzel, unpublished) . This structural alignment was the basis for the sequence alignment (Figure 1 ) for S. aureus and E. coli peptide deformylase. Other sequence alignments were carried out manually so as to conform to the structure-based alignment of each Class. Figure 5 was produced with MOLSCRIPT 59 and Raster 3D 60 . Figures 3, 4ab, 6 , and 7
were prepared with the graphics program MOSAIC2. The coordinates are deposited in the Protein Data Bank, 1LMH.
RESULTS AND DISCUSSION
Comparison of the stability of iron-enriched S. aureus and E. coli peptide deformylase-We have found that the expression of S. aureus peptide deformylase containing a C-terminal hexahistidine tag fusion provides a facile method for purification of this protein. During the course of this work, we also found that the enzymatic activity of the purified form of the Feenriched protein was stable, in sharp contrast to the instability reported for the Fe +2 form of E.
coli peptide deformylase 25 . In order to validate this finding we expressed the iron form of S.
aureus or E. coli peptide deformylase in E. coli after the pre-incubation of the cells in 1.6 mM purified by Ni-NTA chromatography, and then were stored in 10 µg/mL catalase. To examine the stability of the iron-enriched forms of the peptide deformylase proteins, dilutions of the enzymes were made in the presence or absence of catalase (at 100 µg/mL), followed by enzymatic assays under standard conditions as described above. Assays were run using formylMet-Leu-p-nitroanilide as substrate, coupled to the Vibrio aminopeptidase. The E. coli ironenriched peptide deformylase enzyme rapidly loses activity upon dilution in the absence of catalase 24 . On the other hand, the S. aureus Fe-enriched peptide deformylase remains stable regardless of whether catalase is added. Thus, the Fe-enriched form of S. aureus peptide deformylase remains highly active under conditions that result in the rapid inactivation of identically prepared E.coli peptide deformylase (Figure 2) .
Similarly, the metal forms of S. aureus peptide deformylase were prepared by supplementation of E. coli K12 with 1.6 mM FeCl 3 , 640 uM ZnCl 2, or control media, followed by purification by Ni-NTA chromatography as described above (in the absence of catalase) 26, 29 . The peptide deformylase from each experiment (iron-enriched, zinc-enriched, or no supplementation) was then assayed. The addition of zinc lowers the specific activity of the peptide deformylase, while the addition of iron increases the specific activity by 3-6 fold (average) when compared to control media ( Figure 3 ). These data support the notion that the S. aureus, but not E. coli, peptide deformylase enzyme is capable of forming a stable metal complex with iron, while the zinc metal complex with S. aureus peptide deformylase behaves similarly to that described for the Zn +2 form of the E. coli enzyme. . The β-sheet regions surround the centrally located helix and help to create the shallow active site cavity. The β-sheet rich section is composed of three β-sheet elements: an N-terminal anti-parallel three-stranded β-sheet, a central anti-parallel three-stranded β-sheet, and a C-terminal mixed β-sheet. The C-terminus of the protein forms a last short strand of mixed β-sheet and is poised at the mouth of the active site ( Figure 5 ).
Structure of S. aureus peptide deformylase-
Comparison of Class I and Class II Peptide Deformylase
With the availability of numerous E. coli peptide deformylase X-ray and NMR structures, we (Figure 1) . From the simplest comparison of these two X-ray structures one is immediately struck by the obvious difference at the C-terminus ( Figure 5) . The E. coli enzyme has a long protruding α-helix which abutts the protein surface behind the active site cavity. The C-terminus of the S. aureus enzyme does not contain an equivalent α-helix, but wraps around to complete a short stretch of β-sheet, terminating near the opening of the active site cavity. This is the only major topological difference between the two structures ( Figure 6 ).
It follows from the low overall sequence identity between E. coli and S. aureus peptide deformylase, that the lining of the active site cavity would not be identical. This expectation is in fact borne out by the present structure ( Figure 7) . Analysis of the active site cavity suggests that 9 residue changes are found in the crevice and the annulus about the active site depression (Table   3 ). Some particularly interesting differences include the structural replacement of Arg 97 (E. coli)
for Arg 56 (S. aureus) where an arginine side chain is retained in a similar three-dimensional position but the side of the cavity from which it projects is altered. Leucine 125 (E. coli) forms part of the hydrophobic surface that binds the peptide substrate methionine side chain. This residue is replaced with Tyr 147 in S. aureus and the side chain hydroxyl is positioned near the mouth of the active site cavity. In addition a number of subtle hydrophobic-hydrophobic changes are observed as are a number of polar-polar changes.
Our comparison of Class I and Class II peptide deformylase identifies the parameters that will influence the discovery of general inhibitors of this enzyme, as well as those that might be specific for gram-positive or gram-negative bacteria. The sequence and structural identity between enzymes in the immediate vicinity of the active site metal ion suggests that this is the determining locus for general inhibitors (Figure 4b ). 19 . In addition to direct metal chelation, general inhibitors may also be expected to exploit interactions with the conserved catalytic Glu 155 ; Gln 65 (the side chain that projects above the metal from the back of the active site, Figure 4a) ; and main chain interactions with Leu 112 and Gly 110 . Hydrogen bonds with different subsets of these conserved amino acids are observed in the published complexes 2, [32] [33] . While all peptide deformylase enzymes are expected to bind a methionine side chain optimally in the long and fairly narrow hydrophobic S1' subsite 74 , the lack of strict conservation of side chain residues that compose this subsite affords an opportunity for specificity. The left side of the pocket is composed of strictly conserved residues, hydrophobic groups in S1' may be achieved more readily in certain peptide deformylase enzymes. It may also be possible to exploit electronic differences in this subsite, i.e., the free cysteine of the E. coli enzyme is replaced by Val 151 in the present structure ( Figure 7 ).
Because of more prevalent differences in the S2', S3' and S4' subsites between Class I and Class II, designing generality into inhibitors becomes increasingly difficult. The S. aureus enzyme S2' subsite differs from the E. coli enzyme in several important ways. The path the main chain is altered to narrow the subsite at Ser 57 and to project the backbone carbonyl of this residue more directly into the subsite pocket. Arginine 56 forms a lid across the back of the S2' subsite further restricting its size. In the product complex bound to E. coli peptide deformylase 33 , the product makes several key interactions. These include a hydrogen bond between the peptide backbone carbonyl of the product and the side chain of Arg 97 . Equivalent interactions have been seen in other complexes including thermolysin 68 . The possibility for this hydrogen bond is lost in S. 33 with the present structure places the new hydrogen bond donor/acceptor within 3 Å of the product peptide backbone nitrogen. A similar tyrosine hydroxyl hydrogen bond has been observed in human aspartic proteases 75, 76 . The S4' subsite is completely exposed to solvent and does not form a distinct pocket. However, protein surface residues in this region derive from the Class II specific insertion of variable length and may modify the path by which peptide substrates (or inhibitors) approach the active site.
The comparison of E. coli and S. aureus peptide deformylase reveals the structural differences between Class I and II peptide deformylase enzymes, but fails to explain stability differences we observe between the prototypic enzymes. Examination of the active site variation suggests that general inhibitors of peptide deformylase will possess specificity determinates found near the metal and in S1'. However, compounds with realistic drug like molecular weights on the order of 400 to 500 Dalton would most certainly reach into the more divergent S2' and S3' regions. Thus, careful consideration of structural variation across classes will be required for the design of general inhibitors. Conversely, specificity to S. aureus over other bacteria may be introduced by incorporation of specific hydrogen bonding groups into inhibitors that exploit the S2' and S3'
subsites. This structure determination is the essential first step towards a program of structurebased antibiotic discovery centered about a pathologically important target.
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